We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$984M
1-Year Est. Return
72.08%
This Fund
S&P 500
This Quarter
Est. Return
+3.34%
1 Year Est. Return
+72.08%
3 Year Est. Return
+124.02%
5 Year Est. Return
+117.81%
10 Year Est. Return
+397.76%
AUM
$244M
AUM Growth
-$11.5M
(-4.5%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-7.28%
Top 10 Holdings %
Top 10 Hldgs %
27.75%
Holding
287
New
30
Increased
69
Reduced
110
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$14.6M |
| 2 |
Walt Disney
DIS
|
+$10.3M |
| 3 |
Gilead Sciences
GILD
|
+$10.2M |
| 4 |
AbbVie
ABBV
|
+$9.79M |
| 5 |
NLSN
Nielsen Holdings plc
NLSN
|
+$4.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoreCivic
CXW
|
+$6.9M |
| 2 |
The GEO Group
GEO
|
+$6.36M |
| 3 |
MDU Resources
MDU
|
+$6.33M |
| 4 |
Sabra Healthcare REIT
SBRA
|
+$5.72M |
| 5 |
CNA Financial
CNA
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Technology | 10.62% |
| 3 | Communication Services | 10.2% |
| 4 | Consumer Discretionary | 9.47% |
| 5 | Miscellaneous | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MON
1
DELISTED
Monsanto Co
MON
| $14.3M | 5.84% |
+139,510
| New | +$14.6M |
|
|
2
AbbVie
ABBV
$460B
| $10.4M | 4.24% |
164,405
+151,272
| +1,152% | +$9.79M |
|
|
3
Gilead Sciences
GILD
$188B
| $10.1M | 4.15% |
128,022
+125,569
| +5,119% | +$10.2M |
|
|
4
Walt Disney
DIS
$185B
| $9.95M | 4.07% |
+107,112
| New | +$10.3M |
|
|
TIF
5
DELISTED
Tiffany & Co.
TIF
| $5.45M | 2.23% |
75,000
| – | – |
|
|
NLSN
6
DELISTED
Nielsen Holdings plc
NLSN
| $4.31M | 1.77% |
+80,503
| New | +$4.28M |
|
7
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| $3.56M | 1.46% |
41,909
-2,582
| -6% | -$220K |
|
8
iShares 0-1 Year Treasury Bond ETF
SHV
$20.9B
| $3.56M | 1.46% |
32,219
-1,990
| -6% | -$220K |
|
|
VER
9
DELISTED
VEREIT, Inc.
VER
| $3.14M | 1.28% |
60,537
+51
| +0.1% | +$2.65K |
|
10
AT&T
T
$179B
| $3.07M | 1.26% |
100,131
-12,127
| -11% | -$383K |
|
|
RAI
11
DELISTED
Reynolds American Inc
RAI
| $3M | 1.23% |
+63,554
| New | +$3.19M |
|
12
iShares 3-7 Year Treasury Bond ETF
IEI
$17.6B
| $3M | 1.23% |
23,667
-1,523
| -6% | -$193K |
|
13
iShares 7-10 Year Treasury Bond ETF
IEF
$42.2B
| $2.98M | 1.22% |
26,623
-1,809
| -6% | -$203K |
|
14
W.P. Carey
WPC
$16B
| $2.59M | 1.06% |
40,973
-33,249
| -45% | -$2.22M |
|
15
Comcast
CMCSA
$94.6B
| $2.51M | 1.03% |
75,790
-2,128
| -3% | -$70.8K |
|
16
Vanguard S&P 500 ETF
VOO
$1.03T
| $2.46M | 1.01% |
12,394
-671
| -5% | -$133K |
|
17
Carnival Corporation Ltd
CCL
$32.2B
| $2.16M | 0.88% |
44,154
+39,154
| +783% | +$1.81M |
|
|
PPL
18
PPL Corp
PPL
$26.4B
| $2.13M | 0.87% |
61,525
-11,826
| -16% | -$426K |
|
19
Cigna
CI
$75.6B
| $1.91M | 0.78% |
14,640
-240
| -2% | -$31.3K |
|
20
Apple
AAPL
$4.79T
| $1.84M | 0.75% |
65,000
-38,044
| -37% | -$1.01M |
|
21
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.1B
| $1.82M | 0.75% |
20,333
-1,259
| -6% | -$113K |
|
22
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $1.75M | 0.72% |
8,079
+1
| +0% | +$216 |
|
23
Cisco
CSCO
$428B
| $1.72M | 0.7% |
54,085
+1,404
| +3% | +$43.2K |
|
|
EGRX
24
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.68M | 0.69% |
24,000
| – | – |
|
25
Intel
INTC
$485B
| $1.68M | 0.69% |
44,450
-2,749
| -6% | -$97.3K |
|
Similar funds
LI
CPBTD
APFP
CVM
SAA
MHIC
JIR
FPGK
Stanley-Laman Group's Q3 2016 Portfolio in Review
As of Q3 2016, Stanley-Laman Group held 287 positions worth $244M, down 4.5% from $256M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Stanley-Laman Group withdrew a net $17.8M in Q3 2016, closing 41 positions and reducing 110 holdings. Its most notable exit was CoreCivic, an estimated $6.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Stanley-Laman Group opened a new position in Monsanto Co worth $14.3M.
- Stanley-Laman Group's largest Q3 2016 buy was Monsanto Co: 139,510 shares worth $14.3M.
- Stanley-Laman Group added most to Gilead Sciences in Q3 2016, an estimated $10.2M increase.
- Stanley-Laman Group's biggest Q3 2016 reduction was Sabra Healthcare REIT, cutting an estimated $5.72M.
- Stanley-Laman Group fully exited CoreCivic in Q3 2016, selling an estimated $6.9M.
- Stanley-Laman Group's ten largest holdings make up 28% of its $244M portfolio in Q3 2016.
- Stanley-Laman Group opened 30 new positions and closed 41 in Q3 2016.
- Stanley-Laman Group's portfolio value fell 4.5% quarter-over-quarter to $244M.
Based on Stanley-Laman Group's 13F filing for Q3 2016, filed 28 Oct 2016.